Business
The Starpharma (ASX:SPL) share price is 35% below its 52-week high
Shares in mid-cap ASX biopharmaceuticals company Starpharma Holdings Limited (ASX: SPL) have endured a volatile start to 2021. After surging to an all-time high of $2.52 by mid-February, the company’s shares have now plunged more than 35% to just $1.62 as at the time of writing.
While…
Continue Reading
-
General13 hours agoFarmers develop ‘autofill’ tech so agricultural robots can operate around the clock
-
Noosa News19 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop
-
General16 hours agoTrump mulling whether to fire US Fed chair Powell
-
Noosa News19 hours agoNowhere is growing like this corner of Queensland. It’s changing the political game